Back to health care’s other big challenges: Return of the Innovation Accelerator
Check out the three selected projects for the Penn Medicine Center for Health Care Innovation's Innovation Accelerator.
The Penn Year in Review Video
The 2020-21 year has been unique and challenging, yet successful. The University community of students, faculty, and staff overcame significant obstacles to flourish.
A blueprint for designing and synthesizing new, multifunctional materials
By combining theory, computational simulations, chemical synthesis, and assembly, researchers demonstrate how an ‘inverse design’ strategy can create unique materials using difficult-to-mix nanocrysta
NextUp: The Philly biotech company developing an in vivo approach to CAR T-Cell therapy
Interius BioTherapeutics just raised $76 million in seed funding to advance their clinical testing.
Penn’s gene therapy program has signed a 150,000 sq ft lease at a former GlaxoSmithKline property in King of Prussia
“The Penn transaction is an indicator that the entire region is benefiting from the research being done in our world-renowned institutions.”
Webinar Recording: Tips from Early Stage Investors
Gain insight from Venture Capitalists who focus on investing in early stage University startups. Recorded on May 19, 2021.
IQ Motion Control is democratizing advanced servo capabilities
Former I-Corps participant, and current PennovationWorks tenant, IQ Motion Control announced the launch of their newest line of servo motors, the Fortiq BLS42.
Interius Therapeutics raises record-breaking Series A round
A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million
Rapid COVID-19 diagnostic test delivers accurate results within 4 minutes
A low-cost, rapid diagnostic test for COVID-19 developed by Penn Medicine provides COVID-19 results within four minutes with 90% accuracy.
PCI’s Managing Director leads panel discussion on Cellicon Valley with Penn Medicine faculty luminaries
On May 6th, as part of the Cellicon Valley '21 two-day event, John Swartley, Managing Director of PCI, joined Penn Medicine faculty to discuss the commercialization of CAR-T technology